A Study On Obtaining And Storing Biospecimens From Multiple Myeloma

Overview

About this study

The purpose of this study is to enroll subjects with MM at defined stages of their disease course and at specified clinical milestones and collect biospecimens along with clinical data (including treatment). These data will be used to investigate the relationship between genomic, molecular and cellular features of tumor and immune microenvironments and their association with clinical and demographic variables.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Voluntarily agrees to participate by giving written informed consent

  • Male or female ≥18 years of age

  • Has a diagnosis of MM

  • Willingness to provide biospecimens listed

  • Permits medical record review

  • Refer to sub-study protocols for study-specific inclusion criteria

Exclusion Criteria:

  • Refer to sub-study protocols for study-specific exclusion and inclusion criteria

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/08/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Prashant Kapoor, M.D.

Contact us for the latest status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Prashant Kapoor, M.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions